A ruthenium(II) β-carboline complex induced p53-mediated apoptosis in cancer cells

Biochimie

Volumn 95, Issue 11, 2013, Pages 2050-2059

  Chen, Yu ^a   Qin, Meng Ying ^a   Wang, Lei ^a   Chao, Hui ^a   Ji, Liang Nian ^a   Xu, An Long ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Carboline; Anticancer; Apoptosis; p53; Ruthenium(II) complex

Indexed keywords

BETA CARBOLINE; CASPASE; CYTOCHROME C; PROTEIN P53; RUTHENIUM COMPLEX;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SYNTHESIS; TUMOR CELL; TUMOR GROWTH;

ANTICANCER; APOPTOSIS; P53; RUTHENIUM(II) COMPLEX; Β-CARBOLINE;

ANIMALS; APOPTOSIS; CARBOLINES; CELL PROLIFERATION; CYTOCHROMES C; HEP G2 CELLS; HUMANS; MCF-7 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; NEOPLASMS; RUTHENIUM; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84885058466     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.07.016     Document Type: Article

References (52)

1. C.M. Che, and F.M. Siu Metal complexes in medicine with a focus on enzyme inhibition Curr. Opin. Chem. Biol. 14 2010 255 261
2. C.X. Zhang, and S.J. Lippard New metal complexes as potential therapeutics Curr. Opin. Chem. Biol. 7 2003 481 489
3. H.K. Liu, S.J. Berners-Price, F.Y. Wang, J.A. Parkinson, J. Xu, J. Bella, and P.J. Sadler Diversity in G-selective DNA binding modes for an organometallic ruthenium arene complex Angew. Chem. Int. Ed. 45 2006 8153 8156
4. L.L. Li, W.Q. Cao, W.J. Zheng, C.D. Fan, and T.F. Chen Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering DNA damage-mediated p53 phosphorylation Dalton Trans. 41 2012 12766 12772
5. C.P. Tan, S.H. Wu, S.S. Lai, M.X. Wang, Y. Chen, L.J. Zhou, Y.P. Zhu, W. Lian, W.L. Peng, L.N. Ji, and A.L. Xu Synthesis, structures, cellular uptake and apoptosis-inducing properties of highly cytotoxic ruthenium-Norharman complexes Dalton Trans. 40 2011 8611 8621
6. P.C.A. Bruijnincx, and P.J. Sadler New trends for metal complexes with anticancer activity Curr. Opin. Chem. Biol. 12 2008 197 206
7. H.K. Liu, and P.J. Sadler Metal complexes as DNA intercalators Acc. Chem. Res. 14 2011 349 359
8. A.C.G. Hotze, M. Bacac, A.H. Velders, B.A.J. Jansen, H. Kooijman, A.L. Spek, J.G. Haasnoot, and J. Reedijk New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) Complexes J. Med. Chem. 46 2003 1743 1750
9. A. Castonguay, C. Doucet, M. Juhas, and D. Maysinger New ruthenium (II)-letrozole complexes as anticancer therapeutics J. Med. Chem. 55 2012 8799 8806
10. II anticancer complex Chem. Sci. 1 2010 258 270
11. 2+ as a potential light-activated dual-action therapeutic agent Inorg. Chem. 50 2011 9213 9215
12. X. Chen, F. Gao, Z.X. Zhou, W.Y. Yang, L.T. Guo, and L.N. Ji Effect of ancillary ligands on the topoisomerases II and transcription inhibition activity of polypyridyl ruthenium (II) complexes J. Inorg. Biochem. 104 2010 576 582
13. E. Meggers Exploring biologically relevant chemical space with metal complexes Curr. Opin. Chem. Biol. 11 2007 287 292
14. J. Maksimoska, L. Feng, K. Harms, C. Yi, J. Kissil, R. Marmorstein, and E. Meggers Targeting large kinase active site with rigid, bulky octahedral ruthenium complexes J. Am. Chem. Soc. 130 2008 15764 15765
15. M.A. Jakupec, M. Galanski, V.B. Arion, C.G. Hartinger, and B.K. Keppler Antitumor metal compounds: more than theme and variations Dalton Trans. 14 2008 183 194
16. S. Blanck, J. Maksimoska, J. Baumeister, K. Harms, R. Marmorstein, and E. Meggers The art of filling protein pockets efficiently with octahedral metal complexes Angew. Chem. Int. Ed. 51 2012 5244 5246
17. 2 J. Am. Chem. Soc. 133 2011 17,164 17,167
18. S.L. Xiao, W. Lin, C. Wang, and M. Yang Synthesis and biological evaluation of DNA targeting flexible side-chain substituted beta-carboline derivatives Bioorg. Med. Chem. Lett. 11 2001 437 441
19. Y. Li, F.S. Liang, W. Jiang, F.S. Yu, R.H. Cao, Q.H. Ma, X.Y. Da, J.D. Jiang, Y.C. Wang, and S. So DH334, a β-carboline anti-cancer drug, inhibits the CDK activity of budding yeast Cancer Biol. Ther. 6 2007 1193 1199
20. A.C. Castro, L.C. Dang, F. Soucy, L. Grenier, H. Mazdiyasni, M. Hottelet, L. Parent, C. Pien, V. Palombella, and J. Adams Novel IKK inhibitors: β-carbolines Bioorg. Med. Chem. Lett. 13 2003 2419 2422
21. R.H. Cao, W.L. Peng, Z.H. Wang, and A.L. Xu β-Carboline alkaloids: biochemical and pharmacological functions Curr. Med. Chem. 14 2007 479 500
22. C.P. Tan, S.S. Lai, S.H. Wu, S. Hu, L.J. Zhou, Y. Chen, M.X. Wang, Y.P. Zhu, W. Lian, W.L. Peng, L.N. Ji, and A.L. Xu Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis J. Med. Chem. 53 2010 7613 7624
23. E. Corral, A.C.G. Hotze, H.D. Dulk, A. Leczkoeska, A. Rodger, M.J. Hannon, and J. Reedijk Ruthenium polypyridyl complexes and their modes of interaction with DNA: Is there a correlation between these interactions and the antitumor activity of the compounds? J. Biol. Inorg. Chem. 14 2009 439 448
24. 2+ conjugates and their photo cross-linking studies with the complementary DNA strand J. Am. Chem. Soc. 124 2002 13416 13433
25. 2+ J. Inorg. Biochem. 93 2003 247 255
26. B.P. Sullivan, J.M. Calvert, and T.J. Meyer Cis-trans isomerism in (trpy)(PPh3)RuC12. Comparisons between the chemical and physical properties of a cis-trans isomeric pair Inorg. Chem. 19 1980 1404 1407
27. H.R. Snyder, H.G. Walker, and F.X. Werber The synthesis of β-carbolines. V. 1-Amino-β-carboline J. Am. Chem. Soc. 71 1949 527 529
28. A.E. Egger, C. Rappel, M.A. Jakupec, C.G. Hartinger, P. Heffeter, and B.K. Keppler Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells J. Anal. Spectrom. 24 2009 51 61
29. 2+ J. Mol. Struct. 892 2008 485 489
30. 2+ J. Inorg. Biochem. 100 2006 1487 1494
31. R.H. Cao, Q. Chen, X.R. Hou, H.S. Chen, H.J. Guan, Y. Ma, W.L. Peng, and A.L. Xu Synthesis, acute toxicities and antitumor effects of novel 9-substituted β-carboline derivatives Bioorg. Med. Chem. 12 2004 4613 4623
32. 2+ Inorg. Chem. 38 1999 3337 3343
33. E.A. Medlycott, and G.S. Hanan Designing tridentate ligands for ruthenium(II) complexes with prolonged room temperature luminescence lifetimes Chem. Soc. Rev. 34 2005 133 142
34. A. Habtemariam, M. Melchart, R. Fernandez, S. Parsons, I.D. Oswald, A. Parkin, F.P. Fabbiani, J.E. Davidson, A. Dawson, R.E. Aird, D.I. Jodrell, and P.J. Sadler Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N, N-, N, O-, and O, O-chelating ligands J. Med. Chem. 49 2006 6858 6868
35. 2(N-N)]Cl2 with N-N=bpy, phen, dpq, dppz, and dppn ChemMedChem. 3 2008 1104 1109
36. X.X. Yang, L.M. Chen, Y.N. Liu, Y.G. Yang, T.F. Chen, W.J. Zheng, J. Liu, and Q.Y. He Ruthenium methylimidazole complexes induced apoptosis in lung cancer A549 cells through intrinsic mitochondrial pathway Biochimie 94 2012 345 353
37. S.J. Martin, C.P. Reutelingsperger, A.J. McGahon, J.A. Rader, R.C. van Schie, D.M. LaFace, and D.R. Green Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl J. Exp. Med. 182 1995 1545 1556
38. I. Vermes, C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V J. Immunol. Methods 184 1995 39 51
39. R.N. Bhattacharjee, K.S. Park, Y. Kumagai, K. Okada, M. Yamamoto, S. Uematsu, K. Matsui, H. Kumar, T. Kawai, T. Iida, T. Honda, O. Takeuchi, and S. Akira VP1686, a Vibrio type III secretion protein, induces toll-like receptor-independent apoptosis in macrophage through NF-kappaB inhibition J. Biol. Chem. 281 2006 36897 36904
40. R.S. Hotchkiss, A. Strasser, J.E. McDunn, and P.E. Swanson Cell death N. Engl. J. Med. 361 2009 1570 1583
41. J. Li, and J. Yuan Caspases in apoptosis and beyond Oncogene 27 2008 6194 6206
42. + transport, and cisplatin-induced apoptosis in renal Cells J. Biol. Chem. 277 2002 43377 44338
43. C. Gaiddon, P. Jeannequin, P. Bischoff, M. Pfeffer, C. Sirlin, and J.P. Loeffler Ruthenium (II)-derived organometallic compounds induce cytostatic and cytotoxic effects on mammalian cancer cell lines through p53-dependent and p53-independent mechanisms J. Pharmacol. Exp. Ther. 315 2005 14,003 14,011
44. A.L. Gartel Transcriptional inhibitors, p53 and apoptoss Biochim. Biophys. Acta 1786 2008 83 86
45. M.K. Kim, H.L. Oh, B.Y. Choi, H. Lim, Y.H. Cho, and C.H. Lee CR229, a novel derivative of β-carbolin-1-one, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation Cancer Sci. 98 2007 1402 1407
46. V. Vidimar, X.J. Meng, M. Klajner, C. Licona, L. Fetzer, S. Harlepp, P. Hebraud, M. Sidhoum, C. Sirlin, J.P. Loeffler, G. Mellitzer, G. Sava, M. Pfeffer, and C. Gaiddon Induction of Caspase 8 and reactive oxygen species by ruthenium-derived anticancer compounds with improved water solubility and cytotoxicity Biochem. Pharmacol. 84 2012 1428 1436
47. C.R. Pestana, D.P.S. Phelippin, A.C.M. Polizello, D.J. Dorta, S.A. Uyemura, A.C. Santos, F.G. Doro, F.P. Rodrigues, E. Tfouni, and C. Curti Effects on mitochondria of mitochondria-induced nitric oxide release from a ruthenium nitrosyl complex Nitric Oxide 20 2009 24 30
48. 2+ with human telomeric DNA: preferential binding to G-quadruplexes over i-motif Biochimie 92 2010 370 377
49. S. Kepitza, M.A. Jakupec, M. Uhl, B.K. Keppler, and B. Marian The heterocyclic ruthenium (III) complex KP1019 (FFC14A) causes DNA damage and oxidative stress in colorectal tumor cells Cancer Lett. 226 2005 115 121
50. J.B. Lepecp, and C. Paoletti A fluorescent complex between ethidium bromide and nucleic acids: physical-chemical characterization J. Mol. Biol. 27 1967 87 106
51. L.R. Silveira, L. Pereira-Da-Silva, C. Juel, and Y. Hellsten Formation of hydrogen peroxide and nitric oxide in rat skeletal muscle cells during contractions Free Radic. Biol. Med. 35 2003 455 464
52. K. Ito, A. Hirao, F. Arai, K. Takubo, S. Matsuoka, K. Miyamoto, M. Ohmura, K. Naka, K. Hosokawa, Y. Ikeda, and T. Suda Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells Nat. Med. 12 2006 446 451